Nanobac Pharmaceuticals Incorporated (NNBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-1999 | 12-1998 | 12-1997 | |
| Sales | 480 | 10 | 6,840 | 8,770 | 9,940 |
| Cost of Goods | 330 | 4 | 4,410 | N/A | N/A |
| Gross Profit | 150 | 7 | 2,430 | 8,770 | 9,940 |
| Operating Expenses | 3,170 | 1,484 | 5,200 | 12,150 | 12,620 |
| Operating Income | -2,690 | -1,474 | -2,360 | -3,380 | -2,680 |
| Interest Expense | 40 | 0 | 710 | 750 | 690 |
| Other Income | -30 | 4 | 340 | 1,460 | 1,460 |
| Pre-tax Income | -2,760 | -1,470 | -2,730 | -2,670 | -1,910 |
| Net Income Continuous | -2,757 | -1,470 | -2,730 | -2,670 | -1,910 |
| Net Income Discontinuous | -930 | 0 | 0 | N/A | N/A |
| Net Income | $-3,690 | $-1,470 | $-2,730 | $-2,670 | $-1,910 |
| EPS Basic Total Ops | -0.06 | -0.22 | -1.07 | -1.05 | -0.74 |
| EPS Basic Continuous Ops | -0.04 | -0.22 | -1.07 | -1.05 | -0.74 |
| EPS Basic Discontinuous Ops | -0.01 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-2,510 | $-1,474 | $-1,330 | $-2,060 | $-1,240 |